The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity

Rheumatology International
Altinay Goksel KaratepeNurullah Akkoc

Abstract

The aim of this study was to develop a Turkish version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Dougados Functional Index (DFI) and assess their reliability, validity, and sensitivity to change. The Turkish versions of the BASFI and DFI were obtained after a translation and back-translation process. Seventy-one patients with ankylosing spondylitis (AS) were included in the study. For investigation of the reliability of the BASFI and DFI, 36 of the patients recompleted both indices on the following day. To assess validity, the patients were evaluated with the Bath AS Disease Activity Index (BASDAI), Bath AS Metrology Index (BASMI), Bath AS Patient Global Score (BAS-G), physicians' assessment of disease activity, Bath AS Radiology Index-spine (BASRI-s) and sacroiliac joints, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). To assess the sensitivity to change, 16 patients were included in an 8-week home exercise program. In addition, 16 who had been on nonsteroidal anti-inflammatory drug (NSAID) treatment were requested to stop the treatment for 1 to 2 weeks. There were no significant differences in BASFI and DFI scores on two occasions within 24 h (P>0.05). The results showed correlations...Continue Reading

References

Jan 1, 1996·British Journal of Rheumatology·S D JonesA Calin
Mar 8, 2003·Clinical and Experimental Medicine·K J Scalapino, J C Davis
Aug 19, 2003·Annals of the Rheumatic Diseases·T PhamUNKNOWN ASAS Working Group

❮ Previous
Next ❯

Citations

Aug 17, 2010·Rheumatology International·Hatice BodurUNKNOWN Türkiye Romatizma Araştırma ve Savaş Derneği [TRASD] (Turkish League Against Rheumatism) Ankylosing Spondylitis [AS] Study G
Oct 28, 2010·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Hatice BodurZafer Günendi
Aug 5, 2011·International Journal of Impotence Research·E OzkorumakG Ozden
Dec 18, 2013·International Journal of Rheumatic Diseases·Taciser KayaRezzan Gunaydin
May 26, 2009·Joint, Bone, Spine : Revue Du Rhumatisme·Yasemin TuranLale Cerrahoglu
Mar 31, 2011·Rheumatology International·Omer KaradağIhsan Ertenli
Apr 13, 2011·Rheumatology International·Gulcan GurerAyse Iyiyapici Unubol
May 27, 2015·Modern Rheumatology·Esra Erkol İnalMehmet Şahin
Feb 6, 2010·Disability and Rehabilitation·Bekir DurmusErdal Dogan
Aug 3, 2006·Scandinavian Journal of Rheumatology·L AltanM Yurtkuran
Apr 25, 2007·Scandinavian Journal of Rheumatology·O B PedersenP Junker
Mar 20, 2008·Current Opinion in Rheumatology·Francine Ton Nghiem, John Patrick Donohue
Jul 19, 2015·Rheumatology International·Esra Erkol İnalTahsin Yakut
Jun 22, 2020·Rheumatology International·Mehmet Tuncay DuruözTiraje Tuncer
Feb 23, 2020·Modern Rheumatology·Mehmet Tuncay DuruözHatice Şule Baklacıoğlu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.